 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Growth factor
|
PDB id
|
|
|
|
1waq
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
1 term
|
 |
|
Biochemical function
|
growth factor activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
349:933-947
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
A single residue of GDF-5 defines binding specificity to BMP receptor IB.
|
|
J.Nickel,
A.Kotzsch,
W.Sebald,
T.D.Mueller.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Growth and differentiation factor 5 (GDF-5), a member of the TGF-beta
superfamily, is involved in many developmental processes, like chondrogenesis
and joint formation. Mutations in GDF-5 lead to diseases, e.g. chondrodysplasias
like Hunter-Thompson, Grebe and DuPan syndromes and brachydactyly. Similar to
other TGF-beta superfamily members, GDF-5 transmits signals through binding to
two different types of membrane-bound serine-/threonine-kinase receptors termed
type I and type II. In contrast to the large number of ligands, only seven type
I and five type II receptors have been identified to date, implicating a limited
promiscuity in ligand-receptor interaction. However, in contrast to other
members of the TGF-beta superfamily, GDF-5 shows a pronounced specificity in
type I receptor interaction in cross-link experiments binding only to BMP
receptor IB (BMPR-IB). In mice, deletion of either GDF-5 or BMPR-IB results in a
similar phenotype, indicating that GDF-5 signaling is highly dependent on
BMPR-IB. Here, we demonstrate by biosensor analysis that GDF-5 also binds to BMP
receptor IA (BMPR-IA) but with approximately 12-fold lower affinity. Structural
and mutational analyses revealed a single residue of GDF-5, Arg57 located in the
pre-helix loop, being solely responsible for the high binding specificity to
BMPR-IB. In contrast to wild-type GDF-5, variant GDF-5R57A interacts with
BMPR-IA and BMPR-IB with a comparable high binding affinity. These results
provide important insights into how receptor-binding specificity is generated at
the molecular level and might be useful for the generation of receptor subtype
specific activators or inhibitors.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Modeling of the pre-helix loop conformation of
GDF-5 in the bound state. (a) The backbone and side-chain
conformation of several residues located in the pre-helix loop
of free GDF-5 (carbon atoms in gray, GDF-5 in bound conformation
is shown with carbon atoms in green) were adapted to the
conformation observed in the structure of the complex of BMP-2
bound to BMPR-IA (PDB entry 1REW). Residues Phe54 and Pro55 of
GDF-5 were modeled manually to adapt to the torsion angles
observed in BMP-2 bound to BMPR-IA. The side-chain conformation
of Arg57 was changed to adopt an all-trans conformation to avoid
a steric clash with atoms of the receptor molecule upon docking.
(b) BMP-2 in the free state is shown with carbon atoms indicated
in gray; BMP-2 in the bound conformation is shown with carbon
atoms colored green. The change in conformation is rather small;
comparing the structures of BMP-2 in its free form (PDB entry
3BMP) and bound form (PDB entry 1REW) reveals a similar change
in structure suggesting a sort of induced fit upon receptor
binding.
|
 |
Figure 4.
Figure 4. Structural differences for the BMP tryptophan
sequence signature. The b-sheets of fingers 1 and 2 of GDF-5
(blue), BMP-2 (green) and BMP-7 (red) are superimposed,
revealing the structural differences in the loop conformations
of fingers 1 and 2. Although the double tryptophan pattern is
highly conserved in the TGF-b superfamily, the structural
alignment shows significant differences in their main and
side-chain conformations. The differences result in a different
shape of the hydrophobic pocket, which is formed partially by
the tryptophan rings.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2005,
349,
933-947)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.C.Rider,
and
B.Mulloy
(2010).
Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists.
|
| |
Biochem J, 429,
1.
|
 |
|
|
|
|
 |
P.Kasten,
I.Beyen,
D.Bormann,
R.Luginbühl,
F.Plöger,
and
W.Richter
(2010).
The effect of two point mutations in GDF-5 on ectopic bone formation in a beta-tricalciumphosphate scaffold.
|
| |
Biomaterials, 31,
3878-3884.
|
 |
|
|
|
|
 |
Y.F.Liu,
L.S.Zan,
K.Li,
S.P.Zhao,
Y.P.Xin,
Q.Lin,
W.Q.Tian,
and
Z.W.Wang
(2010).
A novel polymorphism of GDF5 gene and its association with body measurement traits in Bos taurus and Bos indicus breeds.
|
| |
Mol Biol Rep, 37,
429-434.
|
 |
|
|
|
|
 |
A.Kotzsch,
J.Nickel,
A.Seher,
W.Sebald,
and
T.D.Müller
(2009).
Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity.
|
| |
EMBO J, 28,
937-947.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Evangelou,
K.Chapman,
I.Meulenbelt,
F.B.Karassa,
J.Loughlin,
A.Carr,
M.Doherty,
S.Doherty,
J.J.Gómez-Reino,
A.Gonzalez,
B.V.Halldorsson,
V.B.Hauksson,
A.Hofman,
D.J.Hart,
S.Ikegawa,
T.Ingvarsson,
Q.Jiang,
I.Jonsdottir,
H.Jonsson,
H.J.Kerkhof,
M.Kloppenburg,
N.E.Lane,
J.Li,
R.J.Lories,
J.B.van Meurs,
A.Näkki,
M.C.Nevitt,
J.Rodriguez-Lopez,
D.Shi,
P.E.Slagboom,
K.Stefansson,
A.Tsezou,
G.A.Wallis,
C.M.Watson,
T.D.Spector,
A.G.Uitterlinden,
A.M.Valdes,
and
J.P.Ioannidis
(2009).
Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand.
|
| |
Arthritis Rheum, 60,
1710-1721.
|
 |
|
|
|
|
 |
J.N.Cash,
C.A.Rejon,
A.C.McPherron,
D.J.Bernard,
and
T.B.Thompson
(2009).
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.
|
| |
EMBO J, 28,
2662-2676.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Nickel,
W.Sebald,
J.C.Groppe,
and
T.D.Mueller
(2009).
Intricacies of BMP receptor assembly.
|
| |
Cytokine Growth Factor Rev, 20,
367-377.
|
 |
|
|
|
|
 |
K.Heinecke,
A.Seher,
W.Schmitz,
T.D.Mueller,
W.Sebald,
and
J.Nickel
(2009).
Receptor oligomerization and beyond: a case study in bone morphogenetic proteins.
|
| |
BMC Biol, 7,
59.
|
 |
|
|
|
|
 |
M.H.Alaoui-Ismaili,
and
D.Falb
(2009).
Design of second generation therapeutic recombinant bone morphogenetic proteins.
|
| |
Cytokine Growth Factor Rev, 20,
501-507.
|
 |
|
|
|
|
 |
N.W.Morrell,
S.Adnot,
S.L.Archer,
J.Dupuis,
P.L.Jones,
M.R.MacLean,
I.F.McMurtry,
K.R.Stenmark,
P.A.Thistlethwaite,
N.Weissmann,
J.X.Yuan,
and
E.K.Weir
(2009).
Cellular and molecular basis of pulmonary arterial hypertension.
|
| |
J Am Coll Cardiol, 54,
S20-S31.
|
 |
|
|
|
|
 |
A.Kotzsch,
J.Nickel,
A.Seher,
K.Heinecke,
L.van Geersdaele,
T.Herrmann,
W.Sebald,
and
T.D.Mueller
(2008).
Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
|
| |
J Biol Chem, 283,
5876-5887.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Tsezou,
M.Satra,
P.Oikonomou,
K.Bargiotas,
and
K.N.Malizos
(2008).
The growth differentiation factor 5 (GDF5) core promoter polymorphism is not associated with knee osteoarthritis in the Greek population.
|
| |
J Orthop Res, 26,
136-140.
|
 |
|
|
|
|
 |
C.Grütter,
T.Wilkinson,
R.Turner,
S.Podichetty,
D.Finch,
M.McCourt,
S.Loning,
L.Jermutus,
and
M.G.Grütter
(2008).
A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions.
|
| |
Proc Natl Acad Sci U S A, 105,
20251-20256.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Eliasson,
A.Fahlgren,
and
P.Aspenberg
(2008).
Mechanical load and BMP signaling during tendon repair: a role for follistatin?
|
| |
Clin Orthop Relat Res, 466,
1592-1597.
|
 |
|
|
|
|
 |
R.Stamler,
H.T.Keutmann,
Y.Sidis,
C.Kattamuri,
A.Schneyer,
and
T.B.Thompson
(2008).
The Structure of FSTL3{middle dot}Activin A Complex: DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY.
|
| |
J Biol Chem, 283,
32831-32838.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Herpin,
and
C.Cunningham
(2007).
Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes.
|
| |
FEBS J, 274,
2977-2985.
|
 |
|
|
|
|
 |
D.Weber,
A.Kotzsch,
J.Nickel,
S.Harth,
A.Seher,
U.Mueller,
W.Sebald,
and
T.D.Mueller
(2007).
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
|
| |
BMC Struct Biol, 7,
6.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Sieber,
F.Plöger,
R.Schwappacher,
R.Bechtold,
M.Hanke,
S.Kawai,
Y.Muraki,
M.Katsuura,
M.Kimura,
M.M.Rechtman,
Y.I.Henis,
J.Pohl,
and
P.Knaus
(2006).
Monomeric and dimeric GDF-5 show equal type I receptor binding and oligomerization capability and have the same biological activity.
|
| |
Biol Chem, 387,
451-460.
|
 |
|
|
|
|
 |
G.P.Allendorph,
W.W.Vale,
and
S.Choe
(2006).
Structure of the ternary signaling complex of a TGF-beta superfamily member.
|
| |
Proc Natl Acad Sci U S A, 103,
7643-7648.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Kraich,
M.Klein,
E.Patiño,
H.Harrer,
J.Nickel,
W.Sebald,
and
T.D.Mueller
(2006).
A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor.
|
| |
BMC Biol, 4,
13.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2006).
Survey of the year 2005 commercial optical biosensor literature.
|
| |
J Mol Recognit, 19,
478-534.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|